InsiderFlow

Kevin Balthaser

ACRS

Kevin Balthaser serves as Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$75.0K

Total Sells

11 trades

$260.7K

Net Position

Net Seller

$185.8K

Companies Traded

1

ACRS

Active Period

Mar 2023 – Feb 2026

12 total trades

Most Recent

Sell ACRS

Feb 3, 2026 · $22.4K

Kevin Balthaser's Insider Trading at Aclaris Therapeutics, Inc. (ACRS)

Buys

1 · $75.0K

Sells

11 · $260.7K

Total Shares Bought

9,490

Total Shares Sold

89,260

ACRS Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Feb 3, 2026↗Sell6,449$3.47$22.4K0
Feb 1, 2026↗Sell4,984$3.51$17.5K0
Dec 31, 2025↗Sell26,645$2.99$79.6K0
Mar 1, 2025↗Sell727$1.99$1.4K0
Feb 1, 2025↗Sell5,816$2.48$14.4K0
Dec 31, 2024↗Sell38,221$2.48$94.8K0
Sep 1, 2024↗Sell286$1.18$337.480
Mar 1, 2024↗Sell1,417$1.24$1.8K0
Jan 1, 2024↗Sell2,536$1.05$2.7K0
Sep 6, 2023↗Buy9,490$7.90$75.0K0
Sep 1, 2023↗Sell285$7.90$2.3K0
Mar 1, 2023↗Sell1,894$12.45$23.6K0

Related Insiders

James Loerop

Chief Business Officer

ACRSSell · Feb 3, 2026

Neal Walker

CEO

ACRSSell · Feb 3, 2026

Explore More Insider Trading Data

ACRS Insider Trading Activity

View all insider trades at Aclaris Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity